Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Détail de l'auteur
Auteur Francis FILLOUX |
Documents disponibles écrits par cet auteur (1)
Faire une suggestion Affiner la recherche
Inhibitory Deficits in Tourette Syndrome: A Function of Comorbidity and Symptom Severity / Sally OZONOFF in Journal of Child Psychology and Psychiatry, 39-8 (November 1998)
[article]
Titre : Inhibitory Deficits in Tourette Syndrome: A Function of Comorbidity and Symptom Severity Type de document : Texte imprimé et/ou numérique Auteurs : Sally OZONOFF, Auteur ; David L. STRAYER, Auteur ; William M. MCMAHON, Auteur ; Francis FILLOUX, Auteur Année de publication : 1998 Article en page(s) : p.1109-1118 Langues : Anglais (eng) Mots-clés : Tourette syndrome information processing classification comorbidity Index. décimale : PER Périodiques Résumé : This study examined central inhibitory function in children with Tourette syndrome (TS; N= 46) and normally developing controls (N= 22) matched on age, gender, and IQ. A negative priming task measured the ability to inhibit processing of irrelevant distractor stimuli presented on a visual display. Initial analyses indicated that participants with Tourette syndrome did not differ significantly in inhibitory function from controls. However, when the large Tourette syndrome sample was separated into subgroups, one without evidence of comorbidity (N= 23) and the other meeting research criteria for either AD/HD, OCD, or both (N= 23), it became evident that individuals with Tourette syndrome with comorbid conditions tended to perform less well than the control group, whereas those without comorbidity performed much like controls. Similarly, when the large Tourette syndrome sample was divided into two subgroups on the basis of severity of symptomatology (N= 23 in each), those with more numerous and severe symptoms of Tourette syndrome, AD/HD, and OCD performed significantly less well than both controls and Tourette syndrome subjects with fewer and less severe symptoms. This suggests that neuropsychological impairment occurs as a function of comorbidity and symptom severity in Tourette syndrome. It also suggests that categorical diagnoses alone may be less useful than dimensional methods for predicting cognitive impairment in individuals with Tourette syndrome. Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=124
in Journal of Child Psychology and Psychiatry > 39-8 (November 1998) . - p.1109-1118[article] Inhibitory Deficits in Tourette Syndrome: A Function of Comorbidity and Symptom Severity [Texte imprimé et/ou numérique] / Sally OZONOFF, Auteur ; David L. STRAYER, Auteur ; William M. MCMAHON, Auteur ; Francis FILLOUX, Auteur . - 1998 . - p.1109-1118.
Langues : Anglais (eng)
in Journal of Child Psychology and Psychiatry > 39-8 (November 1998) . - p.1109-1118
Mots-clés : Tourette syndrome information processing classification comorbidity Index. décimale : PER Périodiques Résumé : This study examined central inhibitory function in children with Tourette syndrome (TS; N= 46) and normally developing controls (N= 22) matched on age, gender, and IQ. A negative priming task measured the ability to inhibit processing of irrelevant distractor stimuli presented on a visual display. Initial analyses indicated that participants with Tourette syndrome did not differ significantly in inhibitory function from controls. However, when the large Tourette syndrome sample was separated into subgroups, one without evidence of comorbidity (N= 23) and the other meeting research criteria for either AD/HD, OCD, or both (N= 23), it became evident that individuals with Tourette syndrome with comorbid conditions tended to perform less well than the control group, whereas those without comorbidity performed much like controls. Similarly, when the large Tourette syndrome sample was divided into two subgroups on the basis of severity of symptomatology (N= 23 in each), those with more numerous and severe symptoms of Tourette syndrome, AD/HD, and OCD performed significantly less well than both controls and Tourette syndrome subjects with fewer and less severe symptoms. This suggests that neuropsychological impairment occurs as a function of comorbidity and symptom severity in Tourette syndrome. It also suggests that categorical diagnoses alone may be less useful than dimensional methods for predicting cognitive impairment in individuals with Tourette syndrome. Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=124